Compare UVSP & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UVSP | BLFS |
|---|---|---|
| Founded | 1876 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 983.8M | 923.5M |
| IPO Year | 1994 | 2013 |
| Metric | UVSP | BLFS |
|---|---|---|
| Price | $33.82 | $18.79 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $35.00 | $32.00 |
| AVG Volume (30 Days) | 142.8K | ★ 463.8K |
| Earning Date | 04-22-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.63% | N/A |
| EPS Growth | 21.32 | ★ 77.27 |
| EPS | ★ 3.13 | N/A |
| Revenue | ★ $328,056,000.00 | $96,214,000.00 |
| Revenue This Year | $11.65 | $19.73 |
| Revenue Next Year | $4.77 | $17.82 |
| P/E Ratio | $10.73 | ★ N/A |
| Revenue Growth | 9.64 | ★ 16.97 |
| 52 Week Low | $24.22 | $17.86 |
| 52 Week High | $36.20 | $29.57 |
| Indicator | UVSP | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 52.40 | 38.90 |
| Support Level | $32.00 | $17.86 |
| Resistance Level | $35.11 | $26.14 |
| Average True Range (ATR) | 0.94 | 0.87 |
| MACD | 0.12 | 0.10 |
| Stochastic Oscillator | 81.54 | 32.18 |
Univest Financial Corp is engaged in domestic banking services for individuals, businesses, municipalities and non-profit organizations. The bank has three operating segments; Banking segment provides financial services including a full range of banking services such as deposit taking, loan origination, and servicing, mortgage banking, other general banking services, and equipment lease financing, Wealth Management segment offers investment advisory, financial planning, trust and brokerage services, and The Insurance segment includes a full-service insurance brokerage agency offering commercial property and casualty insurance, employee benefits solutions, personal insurance lines and human resources consulting. It generates majority of its revenue from the banking segment.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.